Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 13 studies | 41% ± 16% | |
| endothelial cell | 10 studies | 24% ± 13% | |
| astrocyte | 10 studies | 33% ± 16% | |
| oligodendrocyte precursor cell | 9 studies | 30% ± 13% | |
| GABAergic neuron | 8 studies | 41% ± 20% | |
| epithelial cell | 8 studies | 25% ± 8% | |
| adipocyte | 7 studies | 29% ± 6% | |
| glutamatergic neuron | 6 studies | 50% ± 20% | |
| interneuron | 6 studies | 43% ± 19% | |
| fibroblast | 6 studies | 23% ± 6% | |
| smooth muscle cell | 6 studies | 20% ± 3% | |
| cardiac muscle cell | 5 studies | 58% ± 15% | |
| type I pneumocyte | 5 studies | 21% ± 6% | |
| type II pneumocyte | 5 studies | 26% ± 5% | |
| endothelial cell of lymphatic vessel | 4 studies | 15% ± 0% | |
| club cell | 4 studies | 20% ± 5% | |
| kidney loop of Henle epithelial cell | 4 studies | 41% ± 23% | |
| granule cell | 3 studies | 22% ± 2% | |
| neuron | 3 studies | 46% ± 11% | |
| Mueller cell | 3 studies | 19% ± 2% | |
| retinal ganglion cell | 3 studies | 21% ± 6% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 55% ± 22% | |
| renal principal cell | 3 studies | 48% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 3155.28 | 89 / 89 | 99% | 34.20 | 892 / 901 |
| ovary | 99% | 938.96 | 179 / 180 | 99% | 11.48 | 426 / 430 |
| breast | 99% | 914.94 | 456 / 459 | 96% | 14.05 | 1077 / 1118 |
| prostate | 100% | 910.98 | 244 / 245 | 94% | 6.82 | 472 / 502 |
| uterus | 100% | 1498.06 | 170 / 170 | 89% | 11.51 | 410 / 459 |
| lung | 95% | 598.03 | 547 / 578 | 92% | 12.22 | 1062 / 1155 |
| skin | 100% | 3006.52 | 1808 / 1809 | 86% | 9.09 | 407 / 472 |
| esophagus | 100% | 1391.54 | 1443 / 1445 | 86% | 16.01 | 157 / 183 |
| brain | 90% | 674.81 | 2382 / 2642 | 90% | 7.26 | 633 / 705 |
| thymus | 93% | 519.68 | 605 / 653 | 83% | 5.64 | 503 / 605 |
| bladder | 100% | 1412.52 | 21 / 21 | 67% | 5.94 | 337 / 504 |
| pancreas | 75% | 383.52 | 245 / 328 | 84% | 5.67 | 150 / 178 |
| stomach | 100% | 1478.81 | 359 / 359 | 56% | 3.82 | 159 / 286 |
| adrenal gland | 99% | 934.39 | 255 / 258 | 53% | 2.90 | 121 / 230 |
| intestine | 98% | 1801.68 | 943 / 966 | 44% | 2.74 | 234 / 527 |
| muscle | 100% | 5805.57 | 803 / 803 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.15 | 1 / 1 |
| blood vessel | 99% | 1129.70 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 728.98 | 1188 / 1204 | 0% | 0 | 0 / 0 |
| heart | 95% | 2753.70 | 818 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 14.22 | 42 / 45 |
| eye | 0% | 0 | 0 / 0 | 78% | 6.06 | 62 / 80 |
| spleen | 18% | 73.46 | 44 / 241 | 0% | 0 | 0 / 0 |
| liver | 1% | 5.18 | 3 / 226 | 14% | 1.28 | 57 / 406 |
| peripheral blood | 0% | 1.00 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006470 | Biological process | protein dephosphorylation |
| GO_0061053 | Biological process | somite development |
| GO_0000159 | Cellular component | protein phosphatase type 2A complex |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0019888 | Molecular function | protein phosphatase regulator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PPP2R3A |
| Protein name | Protein phosphatase 2 regulatory subunit B''alpha Protein phosphatase 2 (Formerly 2A), regulatory subunit B'', alpha PPP2R3A protein Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B) |
| Synonyms | PPP2R3 |
| Description | FUNCTION: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment. |
| Accessions | ENST00000447251.2 A0PJH4 A0JLT3 H7C1M1 ENST00000334546.6 [Q06190-2] Q06190 Q6P0N9 ENST00000490467.5 [Q06190-3] ENST00000264977.8 [Q06190-1] |